Mohamed Gouda

The University of Texas MD Anderson Cancer Center

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (20)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Collaborators (8)

Scott Tykodi

Fred Hutchinson Cancer Research Center

UNITED STATES

View details

Eleonora Nicolò

Weill Cornell Medicine

UNITED STATES

View details

Nizar M Tannir

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

Paula Pohlmann

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

Michael Gordon

Chief Medical Officer

UNITED STATES

View details

Sarina Piha-Paul

Associate Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

Siqing Fu

Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

Timothy Yap

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Mohamed Gouda

Research Interests

Explore related searches

Contact this professor

Articles (20)

Human Epidermal Growth Factor Receptor 2 Loss following Treatment with Trastuzumab Deruxtecan in Patients with Metastatic Breast Cancer

A phase I/II study of the safety and efficacy of telaglenastat (CB-839) in combination with nivolumab in patients with metastatic melanoma, renal cell carcinoma, and non-small-cell lung cancer

Concordance between Tumor Tissue and Plasma DNA Genotyping in the NCI-MATCH Trial (EAY131)

Cancer in a drop: Liquid biopsy highlights from San Antonio Breast Cancer Symposium (SABCS) 2024

Efficacy assessment in phase I clinical trials: endpoints and challenges

Selinexor (KPT-330) in Combination with Immune Checkpoint Inhibition in Uveal Melanoma: A Phase 1B Trial

A Phase IB Trial of Selinexor in Combination With Immune Checkpoint Blockade in Patients With Advanced Renal Cell Carcinoma

Phase II Study of Copanlisib in Patients With PTEN Loss: Results From NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocols Z1G and Z1H

Selpercatinib mitigates cancer cachexia independent of anti-tumor activity in the HT1080 tumor model.

A Phase Ib Study of Selinexor in Combination with Pembrolizumab in Patients with Metastatic Melanoma

Mutation-Agnostic Detection of Colorectal Cancer Using Liquid Biopsy-Based Methylation-Specific Signatures

Inhibition of the Phosphatidylinositol-3 Kinase Pathway Using Bimiralisib in Loss-of-Function NOTCH1-Mutant Head and Neck Cancer.

Exportin(g) precision oncology beyond genomics with XPO1 inhibition.

Strategies for Mitigating Antibody-Drug Conjugate Related Adverse Events for Precision Therapy.

Precision oncology for biliary tract tumors: it's written in blood!

Longitudinal Monitoring of Circulating Tumor DNA to Predict Treatment Outcomes in Advanced Cancers

Monitoring of Dynamic Changes and Clonal Evolution in Circulating Tumor DNA From Patients With IDH-Mutated Cholangiocarcinoma Treated With Isocitrate Dehydrogenase Inhibitors

Ultrasensitive detection of BRAF V600E mutations in circulating tumor DNA of patients with metastatic thyroid cancer

Ultrasensitive detection of BRAF mutations in circulating tumor DNA of non-metastatic melanoma

Prophylactic cranial irradiation for extensive-stage small cell lung cancer

Collaborators (8)

Scott Tykodi

Eleonora Nicolò

Nizar M Tannir

Paula Pohlmann

Michael Gordon

Sarina Piha-Paul

Siqing Fu

Timothy Yap

Make your next move.